Page last updated: 2024-11-03

ritanserin and Apnea, Obstructive Sleep

ritanserin has been researched along with Apnea, Obstructive Sleep in 2 studies

Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gradwohl, G1
Berdugo-Boura, N2
Segev, Y2
Tarasiuk, A2
Troib, A1

Other Studies

2 other studies available for ritanserin and Apnea, Obstructive Sleep

ArticleYear
Chronic upper airway obstruction induces abnormal sleep/wake dynamics in juvenile rats.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Airway Resistance; Animals; Arousal; Electroencephalography; Rats; Rats, Sprague-Dawley; Ritanserin;

2014
Role of growth hormone-releasing hormone in sleep and growth impairments induced by upper airway obstruction in rats.
    The European respiratory journal, 2011, Volume: 38, Issue:4

    Topics: Animals; Disease Models, Animal; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone;

2011